Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On July 23, Evercore ISI lowered the firm’s price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) from $550 to $535, while keeping an In Line Rating on the stock.
The rating follows the company’s fiscal second-quarter earnings call for 2025. The company exceeded both revenue and EPS expectations during the quarter, driven by improved system sales. Intuitive Surgical, Inc. (NASDAQ:ISRG) posted $2.44 billion in revenue, up 21.4% year-over-year and ahead of expectations by $87.21 million. The EPS of $2.19 also came in ahead of consensus by $0.27.
A medical team performing minimally invasive surgery with a da Vinci Surgical System.
Despite these impressive sales figures, the firm remains uncertain regarding the company’s potential to sustain the momentum gained in the second quarter, thus maintaining a Hold rating on the stock.
Intuitive Surgical, Inc. (NASDAQ:ISRG) develops and markets advanced robotic-assisted surgical systems, including the da Vinci surgical systems and the Ion endoluminal system.
While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.